IntelliSpace Cognition (the platform for assessment of cognitive frustration)

2019: Announcement

In the middle of November, 2019 Philips submitted the first AI platform for assessment of cognitive violations of IntelliSpace Cognition. This first similar solution in a portfolio of the Dutch producer.

The IntelliSpace Cognition system is intended for automation and optimization of neuropsychological tests and allows to estimate objectively progressing of a disease and efficiency of treatment throughout a progressive tense. The initial research of Philips on interest in new AI assistants showed that 92% of neurologists consider the concept of IntelliSpace Cognition attractive to use in clinical practice, and 80% of neurologists said that they will feel more surely, using the IntelliSpace Cognition platform.

Philips submitted the first AI platform for assessment of cognitive violations

The IntelliSpace Cognition system includes different tests which the patient takes, working with the tablet under the minimum control from medical staff. Results are transferred to a cloud computing platform of a system which then reports results to the doctor in a convenient form.

Objective assessment of cognitive violations at people with neurologic diseases - an old problem of doctors, - the CEO of DENT Neurologic Institute Dr. Joseph Fritz noted. - The automated tools and algorithms of AI offer us new opportunities for therapy optimization. The versatility of the arriving information and objectivity of assessment can be very useful at a conversation with patients and their relatives and also can influence therapy scheduling.

Our system will allow to carry out the reliable assessment of cognitive functions with bigger efficiency and scale, than traditional methods, - the chief innovation officer and to the strategy of Philips Jeroen Tas added.

Originally a system a system will extend in the USA. Later it will be brought to other markets.^[1]

Notes